vimarsana.com

Katy Beckermann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A Look at Novel Immune Therapies for Kidney Cancer

Researchers continue to investigate novel immunotherapy drugs for the treatment of renal cell carcinoma.

United statesMichaelb atkinsKaty beckermannEric jonaschVivek narayanInternational kidney cancer symposiumHospital of the university pennsylvaniaNovel therapy developmentKidney cancer symposiumImmunity cycleCancer immunity cycleKidney cancer

Cancer Immunity Cycle Could Inform Development of Novel Immune Therapies in RCC

Further understanding of the cancer immunity cycle could drive the development of novel immune therapies for patients with renal cell carcinoma.

United statesMichaelb atkinsVivek narayanEric jonaschKaty beckermannInternational kidney cancer symposiumHospital of the university pennsylvaniaNovel therapy developmentKidney cancer symposiumImmunity cycleCancer immunity cycleImmune therapiesEarly phase clinical developmentNorth americaConventional immune checkpoint inhibitionRenal cell carcinoma

Aravive to Host Virtual KOL Event on its Late-Stage Oncology Asset Batiraxcept

HOUSTON, May 08, 2023 Aravive, Inc. , a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced it will host a virtual Key Opinion. | May 8, 2023

United statesKatherine fuhKaty beckermannCorey davisVanderbilt university medical centerCancer prevention research institute of texasTranslational coClinical trials groupAravive incProduct development awardKidney cancer clinical consortium department of defenseEuropean commissionVanderbilt ingram cancer centerDivision of gynecologic oncologyLifesci advisorsWashington university in st

vimarsana © 2020. All Rights Reserved.